Searchable abstracts of presentations at key conferences in endocrinology

ea0049ep1246 | Thyroid (non-cancer) | ECE2017

Vitamin D levels in Graves’ disease (GD) are lower than in general population but do not correlate with laboratory and clinical parameters in GD or SNPs associated with GD

Planck Tereza , Shahida Bushra , Malm Johan , Manjer Jonas

Introduction: The role of vitamin D in GD is poorly understood. The aim was to compare vitamin D levels in newly diagnosed patients with GD with the general population and to correlate vitamin D levels at diagnosis with laboratory and clinical parameters in GD. Moreover, we examined genetic variation in genes involved in the vitamin D metabolism and their association with GD.Material and methods: Levels of vitamin D were compared in 292 patients with new...

ea0070oc5.7 | Thyroid | ECE2020

Triiodothyronine (T3) use in hypothyroidism and effects on cancer and mortality

Planck Tereza , Hedberg Fredric , Calissendorff Jan , Nilsson Anton

Background: The prescription of triiodothyronine (T3) for hypothyroidism is increasing worldwide, however, long-term effects of its use are largely unknown. Previous studies have suggested possible association between T3 use and breast cancer. The aim of the study was to examine the effects of T3 use on cancer incidence and mortality.Material: Our sample included the full adult population of individuals living in Sweden with at least three purchases of t...

ea0032p1010 | Thyroid (non-cancer) | ECE2013

Increased TRAb and/or low anti-TPO titers at diagnosis of Graves' disease (GD) are associated with an increased risk of developing ophthalmopathy after onset of GD

Lantz Mikael , Planck Tereza , Asman Peter , Hallengren Bengt

Objective: Patients with low thyroid peroxidase antibodies (anti-TPO) and increased TSH-receptor antibodies (TRAb) at diagnosis of GravesÂ’ disease (GD) have been suggested to have an increased risk to develop GravesÂ’ ophthalmopathy (GO). The aim was to evaluate if GO development can be predicted.Design: Observational study with registration of possible GD and GO risk factors.Methods: Three hundred and ninety nine patients...